GDOC Holdings — Goldman Sachs Future Health Care Equity ETF
All 42 reported holdings of Goldman Sachs Future Health Care Equity ETF (GDOC) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Company | 13.28% | $2.67M |
| Johnson & Johnson | 8.07% | $1.62M |
| Merck & Company, Inc. | 5.94% | $1.20M |
| Guardant Health, Inc. | 5.34% | $1.07M |
| Astrazeneca PLC | 4.84% | $973.76K |
| Thermo Fisher Scientific, Inc. | 4.52% | $909.67K |
| Argenx SE | 4.07% | $818.43K |
| Intuitive Surgical, Inc. | 3.90% | $785.16K |
| Boston Scientific Corp. | 3.78% | $760.40K |
| Hoya Corp. | 3.53% | $709.87K |
| Edwards Lifesciences Corp. | 2.98% | $600.02K |
| Lonza Group AG | 2.80% | $562.94K |
| Dexcom, Inc. | 2.79% | $561.97K |
| Agilent Technologies, Inc. | 2.77% | $556.35K |
| Roivant Sciences Ltd. | 2.39% | $480.92K |
| Cencora, Inc. | 2.34% | $471.38K |
| Apogee Therapeutics, Inc. | 1.97% | $396.16K |
| Royalty Pharma PLC | 1.77% | $355.19K |
| Penumbra, Inc. | 1.61% | $323.07K |
| Mettler-Toledo International, Inc. | 1.59% | $319.94K |
| Vertex Pharmaceuticals, Inc. | 1.48% | $298.51K |
| Goldman Sachs Trust | 1.43% | $287.99K |
| Cytokinetics, Inc. | 1.40% | $281.17K |
| Ionis Pharmaceuticals, Inc. | 1.37% | $276.47K |
| Xenon Pharmaceuticals, Inc. | 1.35% | $272.39K |
| Unitedhealth Group, Inc. | 1.35% | $271.92K |
| Repligen Corp. | 1.26% | $252.61K |
| Insmed, Inc. | 1.11% | $222.48K |
| Galderma Group AG | 1.10% | $220.40K |
| Madrigal Pharmaceuticals, Inc. | 1.06% | $213.83K |
| Revolution Medicines, Inc. | 0.84% | $168.35K |
| Cg Oncology, Inc. | 0.75% | $151.49K |
| Bridgebio Pharma, Inc. | 0.73% | $146.70K |
| Quest Diagnostics, Inc. | 0.72% | $144.42K |
| Rhythm Pharmaceuticals, Inc. | 0.68% | $135.84K |
| Alkermes PLC | 0.57% | $114.04K |
| Sartorius Stedim Biotech SA | 0.55% | $110.78K |
| Praxis Precision Medicines, Inc. | 0.55% | $110.59K |
| Definium Therapeutics, Inc. | 0.51% | $101.94K |
| Spyre Therapeutics, Inc. | 0.35% | $70.56K |
| Insulet Corp. | 0.29% | $57.69K |
| Structure Therapeutics, Inc. | 0.20% | $39.65K |
GDOC overview: performance, fees, allocation and SEC filings